Inhibitor Library

Cat.No.L1100

A unique collection of 4925 inhibitors for high throughput screening (HTS) and high content screening (HCS).

Customise Your Library:

Specific Compounds
Quantities
96 or 384 well Plate Map
Dry/solid or DMSO solution

Cited by 348 Publications

Inhibitor Library Contents

Description & Advantages

• A unique collection of 4925 small molecule inhibitors for high throughput screening (HTS) and high content screening (HCS)

• Includes most Selleck inhibitors, APIs, natural products, and chemotherapeutic agents

• Some inhibitors have been approved by the FDA

• Targets PI3K, VEGFR, and RTK pathway, HDAC, Aurora Kinase, CDK and Cell Cycle regulators, Integrase/Proteasome, Phosphatase etc

• Structurally diverse, medicinally active, and cell permeable

• Rich documentation with structure, IC50, and customer reviews

• NMR and HPLC validated to ensure high purity

Product Details

Formulation	4596 compounds pre-dissolved in 10mM DMSO, 180 compounds pre-dissolved in 10mM water, 139 compounds pre-dissolved in 2mM DMSO and 10 compounds pre-dissolved in 2mM water
Container	96 Deep Well Plate Sealed With Aluminium Foil
Stability	12 months	-20°C	in DMSO
Stability	24 months	-80°C	in DMSO
Shipping	Blue ice or dry ice

Case Studies using Selleck Compound Libraries

Application of GPCR Compound Library in liver cancer (This article was published in Nature (IF

Nature.2019;574(7777):268-272
Application of Kinase Inhibitor Library in colorectal cancer (This article was published in Nature Communications (IF

Nat Commun. 2019 16;10(1):2197
Application of FDA-approved Drug Library in antivirus (This article was published in Cell Research (IF

Cell Res. 2019;29(9):739-753
Application of FDA-approved Drug Library in metabolism (This article was published in Movement Disorders (IF

Mov Disord. 2019;34(3):323-334
Application of Epigenetics Compound Library in acute lymphoblastic leukaemia (This article was published in Blood (IF

Blood. 2019 17;134(16):1323-1336
Application of Inhibitor Library in tumour immunology (This article was published in Cancer Immunol Res (IF

Cancer Immunol Res.2017;5(9):790-803